CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cytokine

• Publication date

  2003-12-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CYTO.2003.08.003PMID 14609568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual Roles of IL-4 in Lung Injury and Fibrosis1

  2003cited by this paper
• IL-13-Induced Chemokine Responses in the Lung: Role of CCR2 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling1

  2002cited by this paper
• Idiopathic pulmonary fibrosis.

  2001cited by this paper
• Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

  2001cited by this paper
• Role of cytokines and cytokine therapy in wound healing and fibrotic diseases.

  2001cited by this paper
• Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis.

  2001cited by this paper
• Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.

  2001cited by this paper
• Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling1

  2001cited by this paper
• Pivotal Role of CCR1-Positive Leukocytes in Bleomycin- Induced Lung Fibrosis in Mice1

  2000cited by this paper
• A Mechanism for the Impaired IFN-γ Production in C-C Chemokine Receptor 2 (CCR2) Knockout Mice: Role of CCR2 in Linking the Innate and Adaptive Immune Responses1

  2000cited by this paper
• Role of Monocyte Chemoattractant Protein-1 in Cardiovascular Remodeling Induced by Chronic Blockade of Nitric Oxide Synthesis

  2000cited by this paper
• Kinetics and Cellular Origin of Cytokines in the Central Nervous System: Insight into Mechanisms of Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis1

  2000cited by this paper
• Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)

  2000cited by this paper
• Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.

  2000cited by this paper
• Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.

  1999cited by this paper
• Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells.

  1999cited by this paper
• MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

  1999cited by this paper
• Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.

  1999cited by this paper
• CCR2: from cloning to the creation of knockout mice.

  1999cited by this paper
• Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.

  1999cited by this paper
• Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.

  1999cited by this paper
• Augmented production of chemokines (monocyte chemotactic protein‐1 (MCP‐1), macrophage inflammatory protein‐1α (MIP‐1α) and MIP‐1β) in patients with systemic sclerosis: MCP‐1 and MIP‐1α may be involved in the development of pulmonary fibrosis

  1999cited by this paper
• Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

  1998cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis.

  1998cited by this paper
• Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation

  1998cited by this paper
• Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1.

  1998cited by this paper
• Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta.

  1997cited by this paper
• Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis.

  1997cited by this paper
• Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.

  1997cited by this paper
• Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.

  1997cited by this paper
• Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells.

  1997cited by this paper
• TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.

  1997cited by this paper
• RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis

  1997cited by this paper
• Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release.

  1996cited by this paper
• Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production.

  1996cited by this paper
• Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors*

  1996cited by this paper
• A role for C‐C chemokines in fibrotic lung disease

  1995cited by this paper
• Chemokine expression in murine experimental allergic encephalomyelitis.

  1995cited by this paper
• Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study.

  1994cited by this paper
• Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury.

  1994cited by this paper
• Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3

  1994cited by this paper
• Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases.

  1994cited by this paper
• Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.

  1994cited by this paper
• Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis.

  1993cited by this paper
• Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells.

  1991cited by this paper
• Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis

  1990cited by this paper
• Secretion by human fibroblasts of monocyte chemoattractant protein-1, the product of gene JE.

  1990cited by this paper
• Human monocyte chemoattractant protein-1 (MCP-1).

  1990cited by this paper
• Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes.

  1989cited by this paper
• Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture.

  1988cited by this paper
• Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line

  year unknowncited by this paper

• Yapping about macrophages in fibrotic lung disease

  2025cites this paper
• Structure-based design of orthosteric and allosteric CCR2 inhibitors for potential IPF therapy

  2025cites this paper
• YAP/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury

  2025cites this paper
• Dectin-1 facilitates lung fungal-mediated pulmonary fibrosis.

  2025cites this paper
• Inhibition of Macrophage Recruitment to Heart Valves Mediated by the C-C Chemokine Receptor Type 2 Attenuates Valvular Inflammation Induced by Group A Streptococcus in Lewis Rats.

  2024cites this paper
• Progression of radio-labeled molecular imaging probes targeting chemokine receptors.

  2024cites this paper
• The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review

  2024cites this paper
• Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.

  2024cites this paper
• Molecular imaging in experimental pulmonary fibrosis reveals that nintedanib unexpectedly modulates CCR2 immune cell infiltration

  2024cites this paper
• CCR2+ monocytes are dispensable to resolve acute pulmonary Pseudomonas aeruginosa infections in WT and Cystic Fibrosis mice.

  2024cites this paper
• Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab

  2024cites this paper
• The multifaceted role of the stroma in the healthy prostate and prostate cancer

  2024cites this paper
• The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice

  2024cites this paper
• Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis

  2023cites this paper
• CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential

  2023cites this paper
• Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis

  2023cites this paper
• Immune Mechanisms of Pulmonary Fibrosis with Bleomycin

  2023cites this paper
• Evaluation of VEGF-A and CCL2 in dogs with brachycephalic obstructive airway syndrome or canine idiopathic pulmonary fibrosis and in normocephalic dogs.

  2022cites this paper
• CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding

  2022cites this paper
• Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis

  2022cites this paper
• The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.

  2021cites this paper
• Dark Side of Cancer Therapy: Cancer Treatment-Induced Cardiopulmonary Inflammation, Fibrosis, and Immune Modulation

  2021cites this paper
• Macrophages in lung fibrosis

  2021cites this paper
• The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis

  2020cites this paper
• Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms.

  2020cites this paper
• Comprehensive pulmonary toxicity assessment of cetylpyridinium chloride using A549 cells and Sprague–Dawley rats

  2020cites this paper
• Microengineered 3D pulmonary interstitial mimetics highlight a critical role for matrix degradation in myofibroblast differentiation

  2020cites this paper
• Microengineered 3D pulmonary interstitial mimetics highlight a critical role for matrix degradation in idiopathic pulmonary fibrosis

  2020cites this paper
• The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine

  2020cites this paper
• Chemokine receptor 2-targeted molecular imaging in pulmonary fibrosis

  2020cites this paper
• Interleukin-17: Friend or foe in organ fibrosis.

  2019cites this paper
• Precancerous niche (PCN), a product of fibrosis with remodeling by incessant chronic inflammation

  2019cites this paper
• The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2+ and CCR5+ IFNγ-producing γδT cells in mice.

  2018influential citation
• ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages

  2018cites this paper
• Anti-Fibrotic Therapies from Other Organs: What the Gut Can Learn from the Liver, Skin, Lung and Heart

  2018cites this paper
• Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants

  2018cites this paper
• Role of Infiltrating Monocytes in the Development of Radiation-Induced Pulmonary Fibrosis

  2018cites this paper
• Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview

  2017cites this paper
• AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis

  2017cites this paper
• Inflammation and Immunity

  2017cites this paper
• Update on novel targets and potential treatment avenues in pulmonary hypertension.

  2016cites this paper
• Loss of CCR2 signaling alters leukocyte recruitment and exacerbates γ-herpesvirus-induced pneumonitis and fibrosis following bone marrow transplantation.

  2016influential citation
• Lrp5/&bgr;‐Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis

  2016cites this paper
• Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome.

  2016cites this paper
• ligand-2 clears apoptotic cells in noninfectious lung A macrophage subpopulation recruited by CC chemokine

  2016cites this paper
• activation in a CCL2/CCR2 axis 2 recruitment and M New concepts of IL-10-induced lung fibrosis: fibrocyte

  2016cites this paper
• Silibinin exerts cancer chemopreventive efficacy via targeting prostate cancer cell and cancer-associated fibroblast interaction

  2015cites this paper
• The Function and Regulation of Macrophage Matrix Metalloproteinase 10 (MMP-10) in Lung Injury and Fibrosis

  2015cites this paper
• Translational Research in Acute Lung Injury and Pulmonary Fibrosis Arginase inhibition prevents bleomycin-induced pulmonary hypertension , vascular remodeling , and collagen deposition in neonatal rat lungs

  2015cites this paper
• Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis.

  2015cites this paper
• Reduced supply of monocyte-derived macrophages leads to a transition from nodular to diffuse lesions and tissue cell activation in silica-induced pulmonary fibrosis in mice.

  2015cites this paper
• Synergistic Effect of Bolus Exposure to Zinc Oxide Nanoparticles on Bleomycin-Induced Secretion of Pro-Fibrotic Cytokines without Lasting Fibrotic Changes in Murine Lungs

  2014cites this paper
• Fibroblasts in fibrosis: novel roles and mediators

  2014cites this paper
• Following the path of CCL2 from prostaglandins to periostin in lung fibrosis.

  2014cites this paper
• The Wound Macrophage

  2014cites this paper
• Amniotic Fluid Stem Cells Inhibit the Progression of Bleomycin-Induced Pulmonary Fibrosis via CCL2 Modulation in Bronchoalveolar Lavage

  2013cites this paper
• Targeted therapies for systemic sclerosis

  2013cites this paper
• Granzyme B deficiency exacerbates lung inflammation in mice after acute lung injury.

  2013cites this paper
• The immunology of fibrosis.

  2013cites this paper
• Treatment of orbital vascular malformations with intralesional injection of pingyangmycin

  2013cites this paper
• Contribution of myeloid cell subsets to liver fibrosis in parasite infection

  2013cites this paper
• Current and novel drug therapies for idiopathic pulmonary fibrosis

  2012cites this paper
• Scleroderma

  2012cites this paper
• Fibrocytes and the pathogenesis of diffuse parenchymal lung disease

  2012cites this paper
• A macrophage subpopulation recruited by CC chemokine ligand-2 clears apoptotic cells in noninfectious lung injury.

  2012cites this paper
• Nickel nanoparticles enhance platelet-derived growth factor-induced chemokine expression by mesothelial cells via prolonged mitogen-activated protein kinase activation.

  2012cites this paper
• Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis

  2012cites this paper
• Current and novel drug therapies for idiopathic pulmonary fibrosis

  2012influential citation
• Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.

  2012cites this paper
• The pathogenesis of pulmonary fibrosis: a moving target

  2012cites this paper
• A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2.

  2012cites this paper
• Current and novel drug therapies for idiopathic pulmonary fibrosis

  2012influential citation
• Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis

  2012cites this paper
• Molecular and cellular mechanisms of pulmonary fibrosis

  2012cites this paper
• Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage.

  2011cites this paper
• Pulmonary Fibrosis in Response to Environmental Cues and Molecular Targets Involved in Its Pathogenesis

  2011cites this paper
• Battling Inflammation in Acute Lung Injury and Acute Respiratory Distress Syndrome: Stem Cell-Based Therapy Targeting the Root Cause ofAcute Lung Injury

  2011cites this paper
• Fibrosis and immune dysregulation in systemic sclerosis.

  2011cites this paper
• Phosphoinositide 3‐kinase γ plays a critical role in bleomycin‐induced pulmonary inflammation and fibrosis in mice

  2011cites this paper
• Prostaglandin E2 and the pathogenesis of pulmonary fibrosis.

  2011cites this paper
• Environment and the Role of Inflammation in Chronic Pulmonary Diseases: The Silent Mediator

  2011cites this paper
• Wound macrophages as key regulators of repair: origin, phenotype, and function.

  2011cites this paper
• Pulmonary & Respiratory Medicine

  2011cites this paper
• New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.

  2011cites this paper
• Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.

  2011cites this paper
• Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

  2011cites this paper
• Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury.

  2010cites this paper
• Strategies for treating idiopathic pulmonary fibrosis

  2010cites this paper
• Antigen-Presenting Cells and their Fcγ and Toll-Like Receptors: Leading Suspects in Autoimmunity

  2010cites this paper
• The immunology of fibrosis: innate and adaptive responses.

  2010cites this paper
• Didecyldimethylammonium chloride induces pulmonary inflammation and fibrosis in mice.

  2010cites this paper
• Loss of negative feedback control of nuclear factor-kappaB2 activity in lymphocytes leads to fatal lung inflammation.

  2010cites this paper
• Cardiovascular , Pulmonary and Renal Pathology Loss of Negative Feedback Control of Nuclear Factor-B 2 Activity in Lymphocytes Leads to Fatal Lung Inflammation

  2010cites this paper
• Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.

  2009cites this paper
• Pulmonary fibrosis: pathogenesis, etiology and regulation

  2009cites this paper
• Cross-talk between MCP-3 and TGFbeta promotes fibroblast collagen biosynthesis.

  2009cites this paper
• Chemokines as Mediators of Toxicant‐Induced Inflammation and Fibrosis

  2009cites this paper
• The role of monocyte-derived cells in influenza-induced pathology and Th1 immune responses

  2009cites this paper
• Expression and regulation of monocyte chemoattractant protein-3 (MCP-3) in fibrosis

  2009cites this paper
• The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients.

  2009cites this paper